Form 4: Revolution Medicines CFO Jack Anders Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Jack Anders, CFO of Revolution Medicines, reports acquiring 26,400 shares of common stock and 92,400 stock options on March 1, 2024.
Summary
- On March 1, 2024, Jack Anders, the Chief Financial Officer of Revolution Medicines, Inc., acquired 26,400 shares of common stock at $0 per share.
- Following this transaction, Anders directly owns 103,220 shares of common stock, which includes 63,726 restricted stock units and 404 shares acquired through the Employee Stock Purchase Plan on November 30, 2023.
- Anders also acquired 92,400 stock options with an exercise price of $29.80 on the same date.
- These options vest monthly, with 1/48th of the shares vesting each month from March 1, 2024, until fully vested on the fourth anniversary, contingent upon continued service.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard regulatory filing. The acquisition of shares and options could be seen as a positive sign, but it's not definitively bullish.
Positives
- The acquisition of shares and stock options by the CFO could be interpreted as a sign of confidence in the company's future prospects.
Future Outlook
The stock options vest monthly from March 1, 2024, indicating a long-term incentive for the CFO.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 11/30/2023 | 404 shares acquired under the Issuer's Employee Stock Purchase Plan |
| 03/01/2024 | Date of transaction: Acquisition of 26,400 shares of common stock and 92,400 stock options. |
| 03/01/2024 | Vesting Commencement Date for stock options. |
| 02/28/2034 | Expiration date of the stock options. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.